Cross Country Healthcare, Inc. (CCRN) P/E Ratio History
Historical price-to-earnings valuation from 2002 to 2024
Loading P/E history...
CCRN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Cross Country Healthcare, Inc. (CCRN) trades at a price-to-earnings ratio of -3.5x, with a stock price of $10.11 and trailing twelve-month earnings per share of $-2.93.
The current P/E is 106% below its 5-year average of 53.5x. Over the past five years, CCRN's P/E has ranged from a low of 3.6x to a high of 571.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, CCRN trades at a 116% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, CCRN trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCRN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CCRN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 27.2 | - | +53%Best | |
| $895M | 8.1Lowest | - | -32% | |
| $3B | 14.3 | 0.74Best | +42% | |
| $7B | 52.7 | - | -4% | |
| $2B | 128.5 | - | -79% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CCRN Historical P/E Data (2002–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $13.84 | $0.23 | 60.8x | +39% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $18.72 | $1.30 | 14.4x | -67% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $22.64 | $2.03 | 11.2x | -74% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $24.79 | $2.82 | 8.8x | -80% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $28.08 | $3.39 | 8.3x | -81% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $22.32 | $4.19 | 5.3x | -88% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $26.57 | $5.01 | 5.3x | -88% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $28.37 | $6.03 | 4.7x | -89% |
| FY2022 Q2 | $20.83 | $5.72 | 3.6x | -92% | |
| FY2022 Q1 | $21.67 | $4.63 | 4.7x | -89% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $27.76 | $3.53 | 7.9x | -82% |
| FY2021 Q3 | $21.24 | $1.59 | 13.4x | -69% |
Average P/E for displayed period: 43.6x
See CCRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCRN — Frequently Asked Questions
Quick answers to the most common questions about buying CCRN stock.
Is CCRN stock overvalued or undervalued?
CCRN trades at -3.5x P/E, below its 5-year average of 53.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does CCRN's valuation compare to peers?
Cross Country Healthcare, Inc. P/E of -3.5x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is CCRN's PEG ratio?
CCRN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2002-2024.